Daratumumab for the Treatment of Multiple Myeloma in Patients With High-Risk Cytogenetic Factors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients With High-Risk Cytogenetic Factors: A Systematic Review and Meta-Analysis
JAMA Oncol 2020 Sep 24;[EPub Ahead of Print], S Giri, A Grimshaw, S Bal, K Godby, P Kharel, B Djulbegovic, MA Dimopoulos, T Facon, SZ Usmani, MV Mateos, LJ CostaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.